“Significance of Serum Monoclonal Proteins in Prognosis and Treatment Decisions for Newly Diagnosed B-Cell Non-Hodgkin Lymphoma”

https://pubmed.ncbi.nlm.nih.gov/38114824

Serum monoclonal proteins based on immunofixation electrophoresis can serve as significant prognostic indicators for newly diagnosed B-cell non-Hodgkin lymphoma, identifying patients with poor prognosis and guiding clinical treatment decisions.